News Details
Timothy J. Eberlein, MD, Elected Chairman of the NCCN Board of Directors; New Officers Elected
Timothy J. Eberlein, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, has been elected Chairman of the NCCN Board of Directors, succeeding Samuel M. Silver, MD, PhD, University of Michigan Comprehensive Cancer Center.
 |
| Timothy Eberlein, MD |
FORT WASHINGTON, PA — Timothy J. Eberlein, MD, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, has been elected Chairman of the National Comprehensive Cancer Network® (NCCN®) Board of Directors. Dr. Eberlein previously served as Vice Chair of the Board and succeeds Samuel M. Silver, MD, PhD, University of Michigan Comprehensive Cancer Center. The change, along with election of new Board officers, was formalized at the NCCN Board of Directors meeting held in conjunction with the NCCN 21st Annual Conference.
“It has been a pleasure to work with Dr. Silver for the past three years and he has left an indelible impact on NCCN from his tenure as Chair of the Board of Directors. We thank him for his service,” said Robert W. Carlson, MD, Chief Executive Officer, NCCN. “Looking forward, we are eager to continue our program growth under the leadership of Dr. Eberlein.”
 |
| Samuel Silver, MD, PhD |
Dr. Eberlein is Director, Alvin J. Siteman Cancer Center; Spencer T. and Ann W. Olin Distinguished Professor; and Bixby Professor and Chairman, Department of Surgery, Washington University School of Medicine. Elected to the National Academy of Sciences’ Institute of Medicine in 2004, Dr. Eberlein is an esteemed surgical oncologist specializing in breast cancer. Throughout his tenure with NCCN, Dr. Eberlein has held leadership roles on a number of committees, including the Executive Committee, Governance Committee, and NCCN Guidelines Steering Committee. “I am looking forward to working with all of the NCCN board members and NCCN staff, with the goal of improving patient care and the patient experience for all people with cancer,” said Dr. Eberlein.
Dr. Silver served as Chairman of the Board since 2013 and will remain a member.
The following members of the NCCN Board were also elected into new offices:
- Vice Chair: Jan C. Buckner, MD, Mayo Clinic Cancer Center
- Secretary: Lori C. Pickens, MHA, Duke Cancer Institute
- Treasurer: Dorothy E. Puhy, MBA, Dana-Farber/Brigham and Women’s Cancer
Center | Massachusetts General Hospital Cancer Center
 |
 |
 |
| Jan Buckner, MD | Lori Pickens, MHA | Dorothy Puhy, MBA |
The NCCN Board of Directors is comprised of two representatives from each NCCN Member Institution who share in NCCN’s mission to improve the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. For more information about NCCN and its leadership, visit NCCN.org.
###
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 27 of the nation’s leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.
The NCCN Member Institutions are: Fred & Pamela Buffett Cancer Center, Omaha, NE; Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; City of Hope Comprehensive Cancer Center, Los Angeles, CA; Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center, Boston, MA; Duke Cancer Institute, Durham, NC; Fox Chase Cancer Center, Philadelphia, PA; Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance, Seattle, WA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; Mayo Clinic Cancer Center, Phoenix/Scottsdale, AZ, Jacksonville, FL, and Rochester, MN; Memorial Sloan Kettering Cancer Center, New York, NY; Moffitt Cancer Center, Tampa, FL; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute, Columbus, OH; Roswell Park Cancer Institute, Buffalo, NY; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO; St. Jude Children’s Research Hospital/The University of Tennessee Health Science Center, Memphis, TN; Stanford Cancer Institute, Stanford, CA; University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, AL; UC San Diego Moores Cancer Center, La Jolla, CA; UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; University of Colorado Cancer Center, Aurora, CO; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; The University of Texas MD Anderson Cancer Center, Houston, TX; University of Wisconsin Carbone Cancer Center, Madison, WI; Vanderbilt-Ingram Cancer Center, Nashville, TN; and Yale Cancer Center/Smilow Cancer Hospital, New Haven, CT.
Clinicians, visit NCCN.org. Patients and caregivers, visit NCCN.org/patients. Media, visit NCCN.org/news.